As of January 22, 2025, MannKind Corp (MNKD) has a market cap of $1.70 billion USD. According to our data, MannKind Corp is ranked No.4403 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.70 B |
-4.04%
|
Dec 31, 2024 | $1.77 B |
76.65%
|
Dec 29, 2023 | $1.00 B |
-30.93%
|
Dec 30, 2022 | $1.45 B |
20.59%
|
Dec 31, 2021 | $1.21 B |
39.62%
|
Dec 31, 2020 | $0.86 B |
142.64%
|
Dec 31, 2019 | $0.36 B |
21.70%
|
Dec 31, 2018 | $0.29 B |
-54.31%
|
Dec 29, 2017 | $0.64 B |
-27.50%
|
Dec 30, 2016 | $0.88 B |
-55.86%
|
Dec 31, 2015 | $2.00 B |
-72.22%
|
Dec 31, 2014 | $7.20 B |
0.38%
|
Dec 31, 2013 | $7.17 B |
125.11%
|
Dec 31, 2012 | $3.19 B |
-7.60%
|
Dec 30, 2011 | $3.45 B |
-68.98%
|
Dec 31, 2010 | $11.11 B |
-7.99%
|
Dec 31, 2009 | $12.08 B |
155.39%
|
Dec 31, 2008 | $4.73 B |
-56.91%
|
Dec 31, 2007 | $10.98 B |
-51.73%
|
Dec 29, 2006 | $22.74 B |
46.45%
|
Dec 30, 2005 | $15.53 B |
-28.51%
|
Dec 31, 2004 | $21.72 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Market Cap | = | MNKD Stock Price | * | MNKD Shares Outstanding |
= | $6.17 | * | 0.28 B | |
= | $1.70 B |